Navegando por Data de Publicação, começando com "2016-08-28"

Filtrar resultados por ano ou mês

Agora exibindo 1 - 2 de 2

Bases de Schiff como potenciais agentes leishmanicidas contra Leishmania chagasi in vitro
(Universidade Federal de São Carlos, 2016-08-28) Coelho, Laiza Gabriela Gavioli; Souza, Clóvis Wesley Oliveira de; https://lattes.cnpq.br/0781683628437007; Anibal, Fernanda de Freitas; https://lattes.cnpq.br/4918261968772806; https://lattes.cnpq.br/2432330596913125
The neglected diseases are a group of diseases with a higher incidence in poor regions and tropical or subtropical climate. The leishmanioses are listed in this group of diseases, which may present themselves in two ways: tegumentary leishmaniasis or Visceral Leishmaniasis (VL). The VL in the new world has as the etiology Leishmania chagasi, which is transmitted by the bite of the sandfly, especially Lutzomya longipalpis. There are some medications used for the treatment of VL, however, still there are recurrence rates and high mortality. In addition to the severe side effects related to these therapies, as Nephrotoxicity, hepatotoxicity and cardiotoxicity. Not long ago it was developed the amphotericin B encapsulated the Liposomes, associated with mild side effects, however still with an onerous cost, being hard to use in regions devoid of resources. In this work we aim to evaluate the activity of 15 compounds with Schiff bases complexed or not the metals (copper, nickel, zinc and iron), to inhibit promastigotes of Leishmania chagasi in vitro, as well as the cytotoxicity of these front of macrophages and fibroblasts in vitro. For tests with the promastigotas 24 hour incubation was carried out to evaluate the feasibility of resazurin method was used. To evaluate the cytotoxicity of compounds was incubated for 24 or 48 hours, using the colorimetric method with MTT. Of the 15 compounds evaluated, 11 showed good activity in inhibiting the promastigotas in the concentrations tested, the cytotoxicity performed with these 11 compounds. Copper complexes (D1, D2, D3) presented best activities when compared with their respective free ligands. However, they also showed cytotoxicity. The compounds complexed with iron (C1 and C3) also showed activity against the promastigotes, showing no or low cytotoxicity front cells, except the C1 that presented certain toxicity front of macrophages. The Methoxy group was what showed best activity when compared to the other free ligands. Generally the free ligands, without metals, were the ones who presented lower cytotoxicity.
Caracterização biofísica da delta-1-pirrolina-5- carboxilato desidrogenase de Trypanosoma cruzi
(Universidade Federal de São Carlos, 2016-08-28) Moraes, Alan Raphael de Farias Klein; Thiemann, Otávio Henrique; https://lattes.cnpq.br/4933022274560322; https://lattes.cnpq.br/8621158784289128
Chagas Disease is a sickness that affects the population present of Latin America and it is classified by the World Health Organization as a Neglected Tropical Diseases. Chagas disease is caused by the flagellated parasite Trypanosoma cruzi, which belong to the same family as Trypanosoma brucei and Leishmania sp., and has a complex life cycle, going from an invertebrate host to a vertebrate one. In order to survive and proliferate in these host changes, T. cruzi must adapt itself to osmotic and oxidative stresses, changes in the environmental ion composition and shifts in energy sources. To perform this adaptation, the amino acid Lproline has presented an important and essential participation that affects the protozoan life cycle, such as support of the mitochondrial metabolism, the host-cell invasion and metacyclogenesis. T. cruzi 1-Delta-Pyrroline-5-Carboxylate Dehydrogenase (TcP5CDH) is involved in the catabolism of proline holding a major role in its conversion by transforming pyrroline-5-carboxylate into L-glutamate (the second step of the catabolic path) and, thus, seeming to be a promising molecular target for new drug development. The amino acids sequence of PP5CDH was used for conservation analysis, secondary structure prediction, identification of functional domains, and building of tertiary structure computer models with the techniques of Molecular Modeling and Molecular Docking. The TcP5CDH (MW: 60 kDa) was expressed in a heterologous fashion in Escherichia coli, and purified with affinity and size exclusion chromatography, resulting in approximately 2 mg/L of expression. The Dynamic Light Scattering assays where carried out with the recombinant P5CDH in the concentrations of 0.5, 1.0, 1.5 e 2.0 mg/mL, and presented an apparent molecular weight of 223,4 kDa (Rh: 12,01 nm), 246,4 kDa (Rh: 12,53 nm), 310,5 kDa (Rh: 13,83 nm) e 312,0 kDa (Rh: 12,13,86 nm), respespectively. The Circular Dichroism spectroscopy was performed with 0.2 mg/mL of TcP5CDH in the presence and absence of 100 μM of NAD+, L-Glu, and its inhibitor Disulfiram, presenting a Tm of Tm 60,01 ºC, 59,76 ºC, 57,76 ºC e 58,18 ºC, showing that TcP5CDH has a more thermic stability without ligands. Also, a deconvolution was made showing that TcP5CDH has 23% of alfa-helix, 12,3% of antiparallel beta-sheetst and 12,4% parallel beta-sheets, 18,3% of turns 41,7% of disorganized structures. These results will contribute to the understanding of the pathway of L- proline in T. cruzi and the possible future development of new drugs.